Alcon (ALC) Total Non-Current Liabilities (2009 - 2026)
Alcon (ALC) posted quarterly Total Non-Current Liabilities of $6.5 billion for Q1 2026, little changed on a QoQ basis from $6.5 billion in Q4 2025.
Alcon (ALC) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Alcon (ALC) has reported Total Non-Current Liabilities for 11 consecutive years, with $6.5 billion the latest figure, recorded in Q1 2026.
- Quarterly Total Non-Current Liabilities changed N/A year-over-year to $6.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 billion (changed N/A YoY) and the FY2025 annual result came in at $6.5 billion, down 0.69% from the prior year.
- Total Non-Current Liabilities steadied at $6.5 billion in Q1 2026 per ALC's latest filing, from $6.5 billion in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for ALC reached as high as $6.9 billion in Q2 2023 and fell as low as $5.8 billion in Q3 2022.
- A 5-year average of $6.5 billion and a median of $6.5 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities dropped 9.52% — and 2023, when it advanced 17.01%.
- Year by year, Total Non-Current Liabilities stood at $6.8 billion in 2022, then slipped by 2.34% to $6.6 billion in 2023, then fell by 1.15% to $6.5 billion in 2024, then dropped by 0.69% to $6.5 billion in 2025, then advanced by 0.17% to $6.5 billion in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $6.5 billion, $6.5 billion, and $6.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 6.48 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 48.37 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 17.13 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 941.16 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 8.65 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06 Bn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 12.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.48 Bn |
| Dec 31, 2025 | 6.47 Bn |
| Sep 30, 2025 | 6.45 Bn |
| Jun 30, 2025 | 6.83 Bn |
| Dec 31, 2024 | 6.52 Bn |
| Sep 30, 2024 | 6.52 Bn |
| Jun 30, 2024 | 6.44 Bn |
| Mar 31, 2024 | 6.47 Bn |
| Dec 31, 2023 | 6.59 Bn |
| Sep 30, 2023 | 6.71 Bn |
| Jun 30, 2023 | 6.86 Bn |
| Mar 31, 2023 | 6.83 Bn |
| Dec 31, 2022 | 6.75 Bn |
| Sep 30, 2022 | 5.82 Bn |
| Jun 30, 2022 | 5.87 Bn |
| Mar 31, 2022 | 6.06 Bn |
| Dec 31, 2021 | 6.27 Bn |
| Sep 30, 2021 | 6.33 Bn |
| Jun 30, 2021 | 6.48 Bn |
| Mar 31, 2021 | 6.49 Bn |